Host defence mechanisms against influenza infection. II. Protection of mice with vaccines against A/Port Chalmers/1/73 and B/Hong Kong/5/72
Identifieur interne : 002B52 ( Main/Exploration ); précédent : 002B51; suivant : 002B53Host defence mechanisms against influenza infection. II. Protection of mice with vaccines against A/Port Chalmers/1/73 and B/Hong Kong/5/72
Auteurs : F. A. Ennis ; M. A. Wells ; D. W. Barry ; S. Daniel ; J. ManischewitzSource :
- Postgraduate Medical Journal [ 0032-5473 ] ; 1976-06.
English descriptors
- Teeft :
- Antibody, Antibody response, Antibody titres, Challenge dose, Challenge virus, Chalmers, Chalmers virus, Control mice, Cpwv, Dilution, Experimental biology, Haemagglutination inhibition antibodies, Higher dilutions, Highest challenge dose, Immune response, Immunization, Individual sera, Influenza, Influenza infection, Influenza vaccines, Influenza virus, Influenza viruses, Kong antigen, Less immunogenic, Lethal challenge, Lower levels, Mouse, Mouse model, Natural exposure, Other vaccines, Same bivalent vaccines, Serial dilutions, Serial passage, Serum antibody, Significant protection, Specific protection, Splitproduct vaccines, Standard deviation, Statistical significance, Subsequent challenge, Titre, Vaccinated animals, Vaccine, Vaccine dilution, Virion, Virus, Virus challenge, Whole virion, Whole virus, Whole virus vaccine, Whole virus vaccines, Young children.
Abstract
Influenza virus strains A2/Port Chalmers/1/73 (H3N2) and B/Hong Kong/5/72 were adapted to mice by serial passage of virus infected mouse lungs. The adapted viruses were used to challenge mice after they had been immunized with serial dilutions of several bivalent vaccines, containing both A/Port Chalmers and B/Hong Kong antigens. Vaccines included both whole virus and split-product preparations disrupted by Tween 80 and ether (ET) or tri-N-butyl phosphate (TBP). These bivalent vaccines induced antibodies and conferred protection to mice against challenge with approximately 30 LD50 of the adapted A2/Port Chalmers virus. Significant protection against lethality (P<0·01) was observed in groups of mice which developed haemagglutinin-inhibition antibody titres of ≥1:16 following immunization. Protection was not statistically significant in groups of mice which developed antibody titres of ≤1:8 to the A/Port Chalmers/1/73 virus following immunization with higher dilutions of certain vaccines. In a similar fashion, current bivalent vaccines containing B/Hong Kong/5/72 stimulated antibodies and conferred significant protection to immunized mice against lethal challenge with the adapted B/Hong Kong virus. Protection was demonstrated against approximately 30 LD50 of adapted virus in groups of mice which developed mean antibodies of ≥1:16. Groups of mice, which developed antibody titres of <1:8 following immunization with certain dilutions of these vaccines, were not significantly protected. These studies confirm and extend observations made with formerly circulating influenza viruses, i.e. immunization with a specific inactivated vaccine in adequate dosage confers protection against a challenge dose of virus lethal to unimmunized mice.
Url:
- https://api.istex.fr/ark:/67375/NVC-GV89HQTS-6/fulltext.pdf
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2496327
DOI: 10.1136/pgmj.52.608.338
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000592
- to stream Istex, to step Curation: 000592
- to stream Istex, to step Checkpoint: 001719
- to stream Main, to step Merge: 002D22
- to stream Pmc, to step Corpus: 000435
- to stream Pmc, to step Curation: 000435
- to stream Pmc, to step Checkpoint: 000E19
- to stream Ncbi, to step Merge: 001364
- to stream Ncbi, to step Curation: 001364
- to stream Ncbi, to step Checkpoint: 001364
- to stream Main, to step Merge: 002C74
- to stream Main, to step Curation: 002B52
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Host defence mechanisms against influenza infection. II. Protection of mice with vaccines against A/Port Chalmers/1/73 and B/Hong Kong/5/72</title>
<author><name sortKey="Ennis, F A" sort="Ennis, F A" uniqKey="Ennis F" first="F. A." last="Ennis">F. A. Ennis</name>
</author>
<author><name sortKey="Wells, M A" sort="Wells, M A" uniqKey="Wells M" first="M. A." last="Wells">M. A. Wells</name>
</author>
<author><name sortKey="Barry, D W" sort="Barry, D W" uniqKey="Barry D" first="D. W." last="Barry">D. W. Barry</name>
</author>
<author><name sortKey="Daniel, S" sort="Daniel, S" uniqKey="Daniel S" first="S." last="Daniel">S. Daniel</name>
</author>
<author><name sortKey="Manischewitz, J" sort="Manischewitz, J" uniqKey="Manischewitz J" first="J." last="Manischewitz">J. Manischewitz</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:0F8F4F8B4496010525F0FEB83231198C23A3879A</idno>
<date when="1976" year="1976">1976</date>
<idno type="doi">10.1136/pgmj.52.608.338</idno>
<idno type="url">https://api.istex.fr/ark:/67375/NVC-GV89HQTS-6/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000592</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000592</idno>
<idno type="wicri:Area/Istex/Curation">000592</idno>
<idno type="wicri:Area/Istex/Checkpoint">001719</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001719</idno>
<idno type="wicri:doubleKey">0032-5473:1976:Ennis F:host:defence:mechanisms</idno>
<idno type="wicri:Area/Main/Merge">002D22</idno>
<idno type="wicri:source">PMC</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2496327</idno>
<idno type="RBID">PMC:2496327</idno>
<idno type="wicri:Area/Pmc/Corpus">000435</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000435</idno>
<idno type="wicri:Area/Pmc/Curation">000435</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000435</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000E19</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000E19</idno>
<idno type="wicri:Area/Ncbi/Merge">001364</idno>
<idno type="wicri:Area/Ncbi/Curation">001364</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001364</idno>
<idno type="wicri:doubleKey">0032-5473:1976:Ennis F:host:defence:mechanisms</idno>
<idno type="wicri:Area/Main/Merge">002C74</idno>
<idno type="wicri:Area/Main/Curation">002B52</idno>
<idno type="wicri:Area/Main/Exploration">002B52</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Host defence mechanisms against influenza infection. II. Protection of mice with vaccines against A/Port Chalmers/1/73 and B/Hong Kong/5/72</title>
<author><name sortKey="Ennis, F A" sort="Ennis, F A" uniqKey="Ennis F" first="F. A." last="Ennis">F. A. Ennis</name>
</author>
<author><name sortKey="Wells, M A" sort="Wells, M A" uniqKey="Wells M" first="M. A." last="Wells">M. A. Wells</name>
</author>
<author><name sortKey="Barry, D W" sort="Barry, D W" uniqKey="Barry D" first="D. W." last="Barry">D. W. Barry</name>
</author>
<author><name sortKey="Daniel, S" sort="Daniel, S" uniqKey="Daniel S" first="S." last="Daniel">S. Daniel</name>
</author>
<author><name sortKey="Manischewitz, J" sort="Manischewitz, J" uniqKey="Manischewitz J" first="J." last="Manischewitz">J. Manischewitz</name>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Postgraduate Medical Journal</title>
<title level="j" type="abbrev">Postgrad Med J</title>
<idno type="ISSN">0032-5473</idno>
<idno type="eISSN">1469-0756</idno>
<imprint><publisher>The Fellowship of Postgraduate Medicine</publisher>
<date type="published" when="1976-06">1976-06</date>
<biblScope unit="volume">52</biblScope>
<biblScope unit="issue">608</biblScope>
<biblScope unit="page" from="338">338</biblScope>
</imprint>
<idno type="ISSN">0032-5473</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0032-5473</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Antibody</term>
<term>Antibody response</term>
<term>Antibody titres</term>
<term>Challenge dose</term>
<term>Challenge virus</term>
<term>Chalmers</term>
<term>Chalmers virus</term>
<term>Control mice</term>
<term>Cpwv</term>
<term>Dilution</term>
<term>Experimental biology</term>
<term>Haemagglutination inhibition antibodies</term>
<term>Higher dilutions</term>
<term>Highest challenge dose</term>
<term>Immune response</term>
<term>Immunization</term>
<term>Individual sera</term>
<term>Influenza</term>
<term>Influenza infection</term>
<term>Influenza vaccines</term>
<term>Influenza virus</term>
<term>Influenza viruses</term>
<term>Kong antigen</term>
<term>Less immunogenic</term>
<term>Lethal challenge</term>
<term>Lower levels</term>
<term>Mouse</term>
<term>Mouse model</term>
<term>Natural exposure</term>
<term>Other vaccines</term>
<term>Same bivalent vaccines</term>
<term>Serial dilutions</term>
<term>Serial passage</term>
<term>Serum antibody</term>
<term>Significant protection</term>
<term>Specific protection</term>
<term>Splitproduct vaccines</term>
<term>Standard deviation</term>
<term>Statistical significance</term>
<term>Subsequent challenge</term>
<term>Titre</term>
<term>Vaccinated animals</term>
<term>Vaccine</term>
<term>Vaccine dilution</term>
<term>Virion</term>
<term>Virus</term>
<term>Virus challenge</term>
<term>Whole virion</term>
<term>Whole virus</term>
<term>Whole virus vaccine</term>
<term>Whole virus vaccines</term>
<term>Young children</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Influenza virus strains A2/Port Chalmers/1/73 (H3N2) and B/Hong Kong/5/72 were adapted to mice by serial passage of virus infected mouse lungs. The adapted viruses were used to challenge mice after they had been immunized with serial dilutions of several bivalent vaccines, containing both A/Port Chalmers and B/Hong Kong antigens. Vaccines included both whole virus and split-product preparations disrupted by Tween 80 and ether (ET) or tri-N-butyl phosphate (TBP). These bivalent vaccines induced antibodies and conferred protection to mice against challenge with approximately 30 LD50 of the adapted A2/Port Chalmers virus. Significant protection against lethality (P<0·01) was observed in groups of mice which developed haemagglutinin-inhibition antibody titres of ≥1:16 following immunization. Protection was not statistically significant in groups of mice which developed antibody titres of ≤1:8 to the A/Port Chalmers/1/73 virus following immunization with higher dilutions of certain vaccines. In a similar fashion, current bivalent vaccines containing B/Hong Kong/5/72 stimulated antibodies and conferred significant protection to immunized mice against lethal challenge with the adapted B/Hong Kong virus. Protection was demonstrated against approximately 30 LD50 of adapted virus in groups of mice which developed mean antibodies of ≥1:16. Groups of mice, which developed antibody titres of <1:8 following immunization with certain dilutions of these vaccines, were not significantly protected. These studies confirm and extend observations made with formerly circulating influenza viruses, i.e. immunization with a specific inactivated vaccine in adequate dosage confers protection against a challenge dose of virus lethal to unimmunized mice.</div>
</front>
</TEI>
<affiliations><list></list>
<tree><noCountry><name sortKey="Barry, D W" sort="Barry, D W" uniqKey="Barry D" first="D. W." last="Barry">D. W. Barry</name>
<name sortKey="Daniel, S" sort="Daniel, S" uniqKey="Daniel S" first="S." last="Daniel">S. Daniel</name>
<name sortKey="Ennis, F A" sort="Ennis, F A" uniqKey="Ennis F" first="F. A." last="Ennis">F. A. Ennis</name>
<name sortKey="Manischewitz, J" sort="Manischewitz, J" uniqKey="Manischewitz J" first="J." last="Manischewitz">J. Manischewitz</name>
<name sortKey="Wells, M A" sort="Wells, M A" uniqKey="Wells M" first="M. A." last="Wells">M. A. Wells</name>
</noCountry>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002B52 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002B52 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= H2N2V1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:0F8F4F8B4496010525F0FEB83231198C23A3879A |texte= Host defence mechanisms against influenza infection. II. Protection of mice with vaccines against A/Port Chalmers/1/73 and B/Hong Kong/5/72 }}
This area was generated with Dilib version V0.6.33. |